Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
François
M
M
Service de Néphrologie et Immunologie Clinique, CHU, Tours, France.
Büchler
M
M
Halimi
J M
JM
Al-Najjar
A
A
Valentin
J F
JF
Thibault
G
G
Lebranchu
Y
Y
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005434:Flow Cytometry; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016131:Lymphocyte Subsets / Q000276:immunology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid